President Barack Obama hinted in February that FDA may be a candidate for sweeping reform amid complaints that it is ill-equipped to handle biotechnology and advances in medicine, according to a report in the Financial Times.
As an example, he cited complaints about the regulatory flexibility of the agency's Center responsible for medical devices. “I've gotten a lot of commentary about the fact that…essentially their model was designed for the kind of medical devices you see in museums,” the president said in remarks before a new panel on jobs and competitiveness. While he was thin on specifics, Obama singled out FDA as an agency that ought to be modernized.
“So, that would be an area where [we should be] getting a group to think strategically about how…we design these regulatory bodies so that they are up to speed and more responsive to a dynamic economy,” Obama said.